维生素B3补充剂用于视神经病变:全面审查
Júlio Almeida1, Tomás R Costa1, Maria Vivas1
1Ophthalmology Department, Prof. Doutor Fernando Fonseca Hospital, EPE, Amadora, Portugal.
概括
维生素B3 (尼古丁胺) 通过支持视网膜质细胞代谢,显示出治疗视觉神经病变的前景,如青光眼. 进一步的研究正在探索其临床疗效和视力保护的最佳剂量.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
背景情况:
- 视神经病变,包括青光眼,是全球不可逆转失明的主要原因.
- 视网膜质细胞 (RGC) 损失是这些疾病的关键病理特征.
- 目前的研究正在寻求有效的疗法来缓解RGC退化.
研究的目的:
- 审查维生素B3 (尼古丁胺) 对视网膜细胞的影响,特别是在视神经病变中.
- 总结关于维生素B3在视神经病变中的临床作用的当前和未来研究.
- 提供关于维生素B3剂量,疗效和副作用的建议.
主要方法:
- 关于维生素B3和视神经病的现有研究的文献综述.
- 对维生素B3在RGCs线粒体代谢中的作用的分析.
- 综合临床试验数据和临床前发现.
主要成果:
- 维生素B3增强RGC中的线粒体代谢,提供神经保护潜力.
- 新出现的证据表明,维生素B3可能会减轻视神经病变中的RGC损失.
- 需要进一步的临床研究来确认疗效并确定最佳参数.
结论:
- 维生素B3 (尼古丁胺) 对视神经病变是一种有前途的治疗途径.
- 了解其在RGC代谢中的作用对于开发新疗法至关重要.
- 对维生素B3的治疗潜力进行临床研究是有必要的.
相关概念视频
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


